These TLSs were stained with CD38, CD138, and CD79a to distinguish GCs (which are CD20− but co-express CD38, CD138, and cytosolic CD79a) from naïve and memory B cells (which are CD38−CD138− but express membranous CD79a) and CD138+ tumor or stromal cells. The gene discussed is CD79A; the disease is neoplasm.